Eltrombopag mobilizes iron in patients with aplastic anemia.

about

Activity of eltrombopag in severe aplastic anemia

P2860

Q59133385-2F37EEAF-A379-4789-BC65-797739B7C819

P2860

Eltrombopag mobilizes iron in patients with aplastic anemia.

Item

http://www.wikidata.org/entity/Q52597951

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Eltrombopag mobilizes iron in patients with aplastic anemia.

@en

Eltrombopag mobilizes iron in patients with aplastic anemia.

@nl

type

Item

label

Eltrombopag mobilizes iron in patients with aplastic anemia.

@en

Eltrombopag mobilizes iron in patients with aplastic anemia.

@nl

prefLabel

Eltrombopag mobilizes iron in patients with aplastic anemia.

@en

Eltrombopag mobilizes iron in patients with aplastic anemia.

@nl

P1476

Eltrombopag mobilizes iron in patients with aplastic anemia.

@en

P2093

Cynthia E Dunbar

http://www.w3.org/2001/XMLSchema#string

Danielle M Townsley

http://www.w3.org/2001/XMLSchema#string

Lori J Sokoll

http://www.w3.org/2001/XMLSchema#string

Michael Streiff

http://www.w3.org/2001/XMLSchema#string

Neal S Young

http://www.w3.org/2001/XMLSchema#string

Qian Sun

http://www.w3.org/2001/XMLSchema#string

Sophie Grasmeder

http://www.w3.org/2001/XMLSchema#string

Thomas Winkler

http://www.w3.org/2001/XMLSchema#string

Zhe Cheng

http://www.w3.org/2001/XMLSchema#string

Zhen Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Eltrombopag inhibits the proliferation of leukemia cells via reduction of intracellular iron and induction of differentiation

Eltrombopag interference in routine chemistry testing.

Eltrombopag: Investigation of Previously Reported Serum Discoloration and Negative Interference on a Total Bilirubin Diazo Method.

Mechanisms for the shuttling of plasma non-transferrin-bound iron (NTBI) onto deferoxamine by deferiprone.

Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug.

Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia.

Eltrombopag and improved hematopoiesis in refractory aplastic anemia.

Metabolism and disposition of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist, in healthy human subjects.

Eltrombopag: a powerful chelator of cellular or extracellular iron(III) alone or combined with a second chelator.

Therapy induced iron deficiency in children treated with eltrombopag for immune thrombocytopenia.

P31

scholarly article

P356

10.1182/BLOOD-2018-01-826784

http://www.w3.org/2001/XMLSchema#string

P407

English

P577

2018-04-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29632023

http://www.w3.org/2001/XMLSchema#string

P932

5969382

http://www.w3.org/2001/XMLSchema#string

Eltrombopag mobilizes iron in patients with aplastic anemia.

about

P2860

P2860

Eltrombopag mobilizes iron in patients with aplastic anemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P577

P698

P932